Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 3.7B | 5.1B | 2.7B | 2.4B |
Cost of revenue | 970.4M | 1.4B | 658.7M | 629.2M |
Gross profit | 2.7B | 3.7B | 2.0B | 1.8B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 893.2M | 1.1B | 656.2M | 496.0M |
Operating income | 1.3B | 2.0B | 847.0M | 755.2M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 136.2M | 139.5M | 137.2M | 139.2M |
Other income expense | — | — | — | — |
Pretax income | 1.3B | 2.1B | 902.2M | 830.6M |
Tax provision | 336.0M | 535.4M | 233.2M | 205.7M |
Net income | 1.0B | 1.6B | 669.0M | 624.9M |
Basic EPS | — | 6.5 | 2.8 | 2.6 |
Diluted EPS | — | 6.5 | 2.8 | 2.6 |
Basic average shares | — | 243.0M | 243.3M | 243.1M |
Diluted average shares | — | 243.0M | 243.3M | 243.1M |
EBITDA | 1.9B | 2.6B | 1.4B | 1.3B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |